Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2026-02-20 @ 6:42 PM
Study NCT ID:
NCT00082667
Status:
TERMINATED
Last Update Posted:
2013-02-25
First Post:
2004-05-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
VICC BRE 0249
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |